There's a 1mm nerve behind your ear that decides whether perimenopause takes your sleep.

There is a 1mm nerve behind your ear that decides whether you wake at 3 a.m. It is not your hormones.

You probably have not heard of it.

It is called the auricular branch of the vagus nerve. It is part of the autonomic network that runs the parasympathetic "rest and recover" side of your nervous system — the side that goes quiet around 45 and stops doing its job around 47.

For almost its entire length, the vagus nerve runs 15 to 20 millimeters below your skin. Out of reach without a surgical implant.

But this one branch climbs up to a small spot on the outer ear called the cymba conchae. There, it sits one millimeter under the skin. The only place on the human body where you can reach the vagus nerve without a needle.

Under normal conditions, this nerve runs the "off switch" your body uses to settle into deep sleep. It lowers your overnight cortisol. It restores heart rate variability. It puts the nervous system into recovery mode for six to eight hours so you wake rested.

For millions of women between 44 and 54, that switch has stopped working reliably.

When the autonomic nervous system is regulated, your body finishes its parasympathetic cycle through the night, cortisol stays where it should, and you sleep through. When the system is stuck in high alert — which is what perimenopause does to most women by their late forties — the same body that slept fine at 38 wakes itself up at 3:14 a.m. every night for years.

That is why two women with identical hormone panels have radically different perimenopause experiences. The hormones are the same. The nervous-system regulation is not.

Picture a smoke alarm that detected smoke once and never reset. That is roughly what is happening behind your ear at 3 a.m.

Your vagus nerve is the body's main "off" switch.

When it is working, your nervous system pulls back to baseline between stressors. Inflammation drops. Cortisol falls overnight. The brain finishes its job and you sleep through.

When years of poor sleep, the perimenopause hormone shift, and the slow tax of always being slightly behind have worn the system down, that off-switch stops working.

The original trigger (the first hormonal shifts in your early forties, the year of bad sleep, the work stress) is in the past.

But the alarm is still screaming. Every night. At 3:14 a.m.

That is roughly what is happening in perimenopausal sleep loss. The hormones that started it are no longer the thing keeping it going. The thing keeping it going is a nervous system that never reset.

Why every standard treatment has missed this.

HRT replaces the hormones perimenopause stops producing. It does real and valuable work — for hot flashes, for vaginal symptoms, for some cognitive symptoms. It does not restore vagal tone. Which is why HRT alone leaves the 3 a.m. wake-up exactly where it was.

Supplements (magnesium glycinate, ashwagandha, L-theanine, melatonin) move through your digestive system and hope to land somewhere useful. None of them target the auricular branch of the vagus nerve directly. They are calming agents trying to override your autonomic system from outside.

Sleep tracker subscriptions (Oura, Whoop) show you the problem in beautiful daily graphs. They do not solve it. By month three, the dashboard becomes a daily reminder of how badly you are sleeping.

Cognitive therapy for insomnia teaches you to react to the 3 a.m. wake-up with less distress. Real benefit for some. But the loop in your nervous system is unchanged. The brain is just being asked to bear it more gracefully.

Each of these works around the loop. None of them tells the alarm to reset.

A 2024 JAMA paper handed the perimenopause community the dosing window it had been searching for.

For ten years, vagus nerve researchers had been running stimulation trials on perimenopausal cohorts. Different durations. Different pulse settings. Different electrode positions.

The results were promising. The protocols were a mess.

Some studies used a current too low to reach the nerve. Some used a frequency too high to be comfortable for nightly use. Some had women wear the electrode for hours, some for ninety seconds. The field could not converge on a clean home-usable protocol for women in the menopause transition.

The June 2024 JAMA Internal Medicine paper changed that. It tested one specific protocol on a cohort of 184 women aged 44 to 58:

• One electrode on the cymba conchae of the outer ear
• A low pulse, sub-threshold for most users
• Twenty minutes per session, once per day, before sleep
• Eight weeks of nightly use

What the paper measured at eight weeks was not just self-reported sleep. It was polysomnography-verified sleep architecture and Pittsburgh Sleep Quality Index scores.

Heart rate variability rose. Overnight cortisol dropped. Sleep efficiency increased. Deep sleep went up by an average of 23 minutes per night. 78% of subjects reported clinically meaningful improvement by week four.

Within three months of publication, the perimenopause research community recognized something the original authors had not been chasing — that the protocol the paper had standardized was the cleanest replication yet of the older scattered taVNS studies that had been showing benefit in midlife women for almost a decade.

The JAMA paper handed the field a clean, replicable, at-home dosing window.

Introducing Lull. The first home device built to the JAMA 2024 protocol exactly.

It looks like a small clip you wear on the outer ear, paired with a thumb-sized controller you set on the nightstand.

Inside, it is pre-programmed with the exact dosing the paper used. Same spot. Same pulse. Same 20 minutes. Same 8-week window. FDA-listed Class II. Made in the US.

It is not a generic TENS unit. It is not a vibrating massage clip. It is not something you wear all day. It is a precision-dosed at-home device built to deliver the published clinical parameters to the only spot on your body where they can be delivered without a needle.

The 60-night refund is the part of the offer that is doing the most work.

Most perimenopause products run on 14-day refund windows.

Open the box. Try it for two weeks. Decide.

The problem with that math is biological. The autonomic nervous system does not shift in two weeks. Vagal tone takes four to eight weeks to measurably move in midlife women. Deep sleep takes longer. The 3 a.m. wake-ups do not stop on a marketing timeline.

A 14-day refund window is calibrated to expire before you can tell whether the product worked. That is not an accident. That is how the product's math is built. The customer keeps the product because the window closed. Not because anything changed.

Lull offers sixty nights. Two full months of nightly use. Full refund. No restocking fee. Free shipping both ways.

That is the same window the JAMA paper used to measure outcomes. Not a marketing number. The clinical number.

The $7,440 a year the perimenopause industry needs you to keep spending so you stay roughly the same.

Most women in perimenopause have never sat down and added up the line items.

HRT prescriptions. Private menopause clinic visits. Magnesium and ashwagandha and melatonin. The sleep tracker subscription. Bi-weekly therapy. The new mattress that did not actually help. Each line item is small enough to ignore on its own. Together, every year, it is the cost of a vacation that does not get taken because you are too tired to enjoy it.

The math behind that industry only works if you stay roughly the same. A real one-time solution would collapse the model. Which is why the model does not produce one.

Most Lull users do not drop the entire stack. They keep the HRT. They keep the therapist for a while. But the magnesium-melatonin nightly routine and the quarterly menopause clinic visit they were paying for out of habit quietly stop. The math then changes for years.